WHO Director-General’s remarks at the Ambassadorial Dialogue on Accelerating Cervical Cancer Elimination – 17 November 2026

17 November 2026
Remarks
Geneva, Switzerland
Reading time:

Ambassador Leslie Ramsammy, 

Ambassador Aashna Kanhai,

Ambassador Riaz Hamidullah,

Ambassador Anne-Claire Amprou,

Excellencies, Ambassadors,

Dr Haileyesus Getahun,

Dear colleagues and friends,

I thank Ambassador Ramsammy and the Permanent Mission of Guyana, and of course my brother Dr Haileyesus Getahun and the Global Centre for Health Diplomacy and Inclusion, for bringing us together.

I want to disclose something: we were going to host something, but when we saw this initiative, we said it was better to join, rather than duplicate, because to join is more united and a better outcome.

In May 2018, WHO – as Haile said – announced an unprecedented call to action to eliminate cervical cancer. This is the first time we dared to dream it was possible to eliminate any cancer. 

And in 2020, in the midst of the COVID-19 pandemic, WHO launched the Global Strategy to Accelerate the Elimination of Cervical Cancer, and later that year the World Health Assembly adopted a resolution formally establishing the strategy.

It set three targets for 2030: 90% of girls vaccinated against HPV; 70% of women screened; and 90% of women with cervical disease treated.

Six years on there is much to be encouraged by.

166 countries have now introduced HPV vaccination. Single-dose schedules mean the vaccines we have can reach far more girls.

Self-sampling means women can be tested without a clinical examination, and devices to treat precancer are available in 112 countries.

But the gap between policy and practice is still wide.

Most countries now have national screening guidelines. Yet in 2022, only 7% of women aged 30 to 39 had ever been screened with an HPV test.

And globally, only 33% of girls were vaccinated against HPV last year.

So this is 33% against the 90% for 2030, so that’s a huge gap.  There is huge progress, but most of what is to be done remains ahead of us.

Cervical cancer still kills about 280 000 women every year, overwhelmingly in low- and middle-income countries. 

Almost all of those deaths could have been prevented.

That makes this a question not only of public health, but of equity, gender equality and women’s rights. 

Whether a woman survives should not depend on where she lives or how much she earns.

Vaccination is advancing. Screening and treatment are lagging behind. That is where the next four years must focus.

Allow me to highlight three priorities.

First, screening must become an organized public health programme, not something women find by chance.

Vaccination programmes know which girls are eligible, deliver the vaccine and track who has received it. Screening needs the same discipline.

Every woman should know when she is due to be screened. 

And every woman who tests positive should be followed up and treated without delay, with respect for her dignity, privacy and right to make informed choices about her health.

That means designing strong primary health care and referral systems that address the barriers women actually face, including cost, distance, stigma, caregiving responsibilities and limited decision-making autonomy.

Second, we must sustain the momentum on vaccination, by reaching girls who are out of school or have missed their dose, or by working with communities to address misinformation.

Third, cervical cancer elimination must be a national investment priority, financed as part of each country’s path to universal health coverage.

International partners must align behind national plans, and invest in the systems that deliver care.

Excellencies,

2030 is a milestone, not the finish line. A girl vaccinated this year will need screening twenty years from now. 

The systems we build today must be there for her then.

This is the last time I will mark World Cervical Cancer Elimination Day as Director-General, before my term ends in August next year. 

I am proud of how far we have come, and conscious of how far we still have to go.

I ask each of you to keep cervical cancer elimination on the agenda in your capitals and here in Geneva, and to turn political commitment into sustained investment.

And I ask you to make sure that women and girls are not only the beneficiaries of these programmes, but help to shape them.

We made history by committing to eliminate a cancer. Now we must deliver on that commitment, for every woman, in every country.

And I support also the question that the Ambassador and Haile raised, a very important question. I think it will give our initiative energy, I’m glad we’re going to discuss that, but from WHO’s side, full support.

I thank you.